Fast‑moving regulation demands clear, compliant storytelling. Ground campaigns in approved labelling and use the FDA’s newly published CRLs to pre‑empt pitfalls and sharpen claims—across every channel. Read ICON’s lat...
ICON portfolio of AI tools drives clinical trial efficiencies
Enterprise Ireland grant awarded to ICON to further enhance artificial intelligence capabilities
Read the press releaseBiomarker and trial optimisation needed to drive R&D progress in Alzheimer’s and related disorders
ICON survey
Read the press release